CHRONIC KIDNEY DISEAS - PowerPoint PPT Presentation

1 / 28
About This Presentation
Title:

CHRONIC KIDNEY DISEAS

Description:

CHRONIC KIDNEY DISEAS Hisham Abdelwahab MRCP U.K MMed/SCI Common presentation of CKD Asymptomatic urine abnormalities : proteinuria/ hgaematuria Nephritic/Nephrotic ... – PowerPoint PPT presentation

Number of Views:50
Avg rating:3.0/5.0
Slides: 29
Provided by: gpCardif
Category:
Tags: chronic | diseas | kidney

less

Transcript and Presenter's Notes

Title: CHRONIC KIDNEY DISEAS


1
CHRONIC KIDNEY DISEAS
  • Hisham Abdelwahab MRCP U.K MMed/SCI

2
(No Transcript)
3
(No Transcript)
4
(No Transcript)
5
Common presentation of CKD
  • Asymptomatic urine abnormalities
  • proteinuria/ hgaematuria
  • Nephritic/Nephrotic syndrome
  • Hypertension
  • Unexplained anaemia
  • Incidental finding of elevated serum Creatinine
  • Uraemic emergencies

6
Screening Methods
  • Serum Creatinine
  • Estimated glomerular filtration rate (GFR)
  • Urine testing

7
Serum Creatinine
  • Sr creatinine is poor reflection of early renal
    disease/failure
  • Damage lt 60 sr creatinine still normal
  • Almost all early renal failure patients are
    asymptomatic
  • SCREENING IS THEREFORE VERY IMPORTANT

8
Estimated Glomerular Filtration rate
  • Estimate of GFR by the Cockcroft and Gault
    equation

1.23 x (140-Age) x BW Sr Cr (umol/l)
Man
1.04 x (140-Age) x BW Sr Cr (umol/l)
Woman
9
Estimated Glomerular Filtration rate
  • MDRD
  • eGFR (mL/min/1.73m2) 186 x SerumCreatinine(umol/
    L) x 0.0113-1.154 x Age(years)-0.203 (x 0.742 if
    female)

10
Continued.
  • The formula is named after the Modification of
    Diet in Renal Disease study in the USA.
  • The results are expressed relative to a standard
    body surface area of 1.73 m2 to allow for
    different body sizes.
  • The equation is only valid in persons over 17
    years of age.
  • Results gt60 mL/min/1.73m2 are likely to deviate
    from the true value and should not be relied
    upon.
  • The use of the eGFR in patients on dialysis is
    inappropriate and will give misleading results.

11
Urine Testing
  • Urine for protein
  • Dipstick
  • 24 hour urinary protein
  • Urine microscopic examination
  • For RBC / Pus Cell / Cast
  • Urine for microalbuminuria
  • On morning urine sample
  • using strip for microalbumin

12
Targets for Screening
  • Hypertensive patients
  • Diabetic patients
  • Cardiovascular disease
  • Proteinuria
  • Hematuria
  • Those on regular NSAID/Herbs
  • Renal calculi
  • Anemia of unknown aetiology
  • First and second degree relatives of ESRD
  • Autoimmune disease (SLE/RA)
  • Reduction of kidney mass(Nephrectomy

13
Screening for proteinuria
Urine dipstick for protein
Positive (Urine protein gt300mg/l) On 2 separate
occasions (exclude other causes)
Overt Nephropathy Quantify excretion rate 24HUP
Negative
Screen for Microalbuminuria (on early morning
spot urine)
Positive
3-6 monthly follow-up of
microalbuminuria Optimise glycaemic
control Strict Bp control ACE/ARB Stop
smoking Lifestyle modification Treat
hyperlipidaemia Avoid excessive protein
intake Monitor renal function Monitor other
endorgan damage
Retest twice in 3-6/12 Exclude other cause
Negative
If 2 of test are positive Diagnosis of
microalbuminuria Is established
Yearly test
14
False ve CKD
  • Urinary Tract Infection
  • Sepsis
  • Heart Failure
  • Strenous exercise
  • Heavy protein intake
  • Menses
  • DHCCB

15
Significance of proteinuria
  • A dominant risk factor for deterioration of renal
    failure (besides HT)
  • Marker of Increased Risk for CV mortality and
    morbidity (DM non-DM)
  • e.g. Microalbuminuria is associated with a 100-
    150 increase in death rate
  • (Mogensen CE, New Eng. J. Med 1984310310-60)

16
Evaluation of Symptomatic Haematuria
17
Who should take the lead? The
primary care physician and The nephrologists
PRIMARY CARE PHYSICIAN
NEPHROLOGISTS
Diagnosis Management Pre Dialysis care
Screening Diagnosis Treatment
18
(No Transcript)
19
CKD
20
Risk factors for progression of CKD
  • Hypertension
  • Hyperglycemia
  • Proteinuria
  • Coffe
  • Smoking
  • Salt

21
(No Transcript)
22
(No Transcript)
23
(No Transcript)
24
ACE
IDNT (n1715)
REIN (n352)
CAPTOPRIL (n409)
RENAAL (n1513)
25
(No Transcript)
26
CALM2000
27
Conclusion
  • Management of ESRD poses an immense challenge to
    healthcare systems all over the world
  • Incidence continue to increase and nearly half of
    the patients are diabetic
  • Patients with ESRD have many other medical
    complications especially CVD
  • Retarding the progression renal failure in
    patients with CKD may reduce the burden of ESRD

28
  • ACE I ,ARB Non DHCCB (Verapamil)
  • lt 25 deterioration in base line creatinine level
    is acceptable following introduction of ACE I ,ARB
Write a Comment
User Comments (0)
About PowerShow.com